Matthew Scott Harris Altimmune, Inc. (ALT) insider trading activity

ALT Quotes by TradingView

Matthew Scott Harris is Chief Medical Officer of Altimmune, Inc.. Currently has a direct ownership of 55,119 shares of ALT, which is worth approximately $422,762. The most recent transaction as insider was on Jul 31, 2024, when has been sold 1,486 shares (Common Stock, par value $0.0001) at a price of $5.41 per share, resulting in proceeds of $8,039. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.1K
0% 3M change
62.11% 12M change
Total Value Held $422,762

Matthew Scott Harris Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 31 2024
BUY
Grant, award, or other acquisition
$8,039 $5.41 p/Share
1,486 Added 2.63%
55,119 Common Stock, par valu...
Feb 02 2024
SELL
Payment of exercise price or tax liability
$21,734 $9.32 p/Share
2,332 Reduced 4.17%
53,633 Common Stock, par valu...
Feb 02 2024
BUY
Exercise of conversion of derivative security
-
7,775 Added 12.2%
55,965 Common Stock, par valu...
Feb 01 2024
SELL
Payment of exercise price or tax liability
$17,793 $9.88 p/Share
1,801 Reduced 3.6%
48,190 Common Stock, par valu...
Feb 01 2024
BUY
Exercise of conversion of derivative security
-
6,166 Added 10.98%
49,991 Common Stock, par valu...
Jan 31 2024
BUY
Grant, award, or other acquisition
$8,761 $2.69 p/Share
3,257 Added 6.92%
43,825 Common Stock, par valu...
Jan 30 2024
SELL
Payment of exercise price or tax liability
$26,548 $9.8 p/Share
2,709 Reduced 6.26%
40,568 Common Stock, par valu...
Jan 30 2024
BUY
Exercise of conversion of derivative security
-
9,275 Added 17.65%
43,277 Common Stock, par valu...
Jul 31 2023
BUY
Grant, award, or other acquisition
$1,941 $2.81 p/Share
691 Added 1.99%
34,002 Common Stock, par valu...
Mar 23 2023
BUY
Open market or private purchase
$42,200 $4.22 p/Share
10,000 Added 23.09%
33,311 Common Stock, par valu...
Feb 02 2023
SELL
Payment of exercise price or tax liability
$35,554 $15.04 p/Share
2,364 Reduced 9.21%
23,311 Common Stock, par valu...
Feb 02 2023
BUY
Exercise of conversion of derivative security
-
7,775 Added 23.24%
25,675 Common Stock, par valu...
Feb 01 2023
SELL
Payment of exercise price or tax liability
$30,081 $13.78 p/Share
2,183 Reduced 10.87%
17,900 Common Stock, par valu...
Feb 01 2023
BUY
Exercise of conversion of derivative security
-
6,166 Added 23.49%
20,083 Common Stock, par valu...
Jan 31 2023
BUY
Grant, award, or other acquisition
$13,232 $10.21 p/Share
1,296 Added 8.52%
13,917 Common Stock, par valu...
Jul 31 2022
BUY
Grant, award, or other acquisition
$7,381 $6.86 p/Share
1,076 Added 7.86%
12,621 Common Stock, par valu...
Feb 28 2022
SELL
Open market or private sale
$225,600 $7.52 p/Share
30,000 Reduced 72.21%
11,545 Common Stock, par valu...
Feb 28 2022
BUY
Exercise of conversion of derivative security
$57,600 $1.92 p/Share
30,000 Added 41.93%
41,545 Common Stock, par valu...
Feb 01 2022
SELL
Payment of exercise price or tax liability
$17,420 $7.98 p/Share
2,183 Reduced 15.9%
11,545 Common Stock, par valu...
Feb 01 2022
BUY
Exercise of conversion of derivative security
-
6,166 Added 30.99%
13,728 Common Stock, par valu...
Jan 31 2022
BUY
Grant, award, or other acquisition
$12,348 $6.86 p/Share
1,800 Added 19.23%
7,562 Common Stock, par valu...
Jul 31 2021
BUY
Grant, award, or other acquisition
$5,590 $7.71 p/Share
725 Added 11.18%
5,762 Common Stock, par valu...
Jan 31 2021
BUY
Grant, award, or other acquisition
$11,752 $12.14 p/Share
968 Added 16.12%
5,037 Common Stock, par valu...
Nov 12 2020
SELL
Open market or private sale
$40,230 $10.02 p/Share
4,015 Reduced 49.67%
4,069 Common Stock, par valu...
MSH

Matthew Scott Harris

Chief Medical Officer
Gaithersburg, MD

Track Institutional and Insider Activities on ALT

Follow Altimmune, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALT shares.

Notify only if

Insider Trading

Get notified when an Altimmune, Inc. insider buys or sells ALT shares.

Notify only if

News

Receive news related to Altimmune, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALT